CORLANOR
What it isSelective funny-current inhibitor in the sinus node; heart failure and inappropriate sinus tachycardia.
Why this oneIt slows the heart without lowering blood pressure or contractility, so it works when beta blockade is maximal or not tolerated.
What limits itFetal toxicity, and it only works in sinus rhythm. Luminous phenomena; CYP3A4-dependent.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Stable symptomatic heart failure (reduce hospitalization) | Adult | 5 mg BID (2.5 mg BID if vulnerable or conduction defect) | titrate to resting HR 50-60 bpm | 7.5 mg BID |
Titration Reassess after 2 weeks, then adjust by 2.5 mg BID based on resting heart rate.
Renal No adjustment for CrCl ≥15 mL/min; no data if CrCl <15 mL/min.
Hepatic No adjustment in mild-moderate impairment; contraindicated in severe (Child-Pugh C).
Pregnancy May cause fetal harm (cardiac teratogenicity in animals); advise effective contraception.
Lactation Undefined
NO BOXED WARNINGS
Principal riskFetal toxicity; it works only in sinus rhythm
Cost, est. cash$300–$2,500/month
Generic entry2021
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Open Ivabradine in the interactive console ↗

